Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/01/2009US20090247512 Macrocylic inhibitors of hepatitis c virus
10/01/2009US20090247510 Use Of Irbesartan For The Preparation Of Medicinal Products That Are Useful For Preventing or Treating Pulmonary Hypertension
10/01/2009US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders
10/01/2009US20090247508 Benzoimidazole Compounds
10/01/2009US20090247507 Enzyme Inhibitors
10/01/2009US20090247506 Antibacterial agents
10/01/2009US20090247505 Spiro(5.5)undecane derivatives
10/01/2009US20090247504 Indazole Derivatives for Treatment of Alzheimer's Disease
10/01/2009US20090247503 5-demethoxyfumagillol and derivatives thereof
10/01/2009US20090247502 Substituted pyridoxazines
10/01/2009US20090247501 Protein kinase inhibitors
10/01/2009US20090247500 Novel compounds as cannabinoid receptor ligands
10/01/2009US20090247499 Sulfonylated piperazines as cannabinoid-1 receptor modulators
10/01/2009US20090247498 Pharmaceutical Compositions Primarily for the Treatment and Prevention of Genitourinary Infections and their Extragenital Complications
10/01/2009US20090247497 Formulation and use of ergosta-7,22-dien-3beta-ol
10/01/2009US20090247496 Pharmaceutical composition and extract of poria for enhancing uptake of nutrients
10/01/2009US20090247495 Cucurbitacin b and uses thereof
10/01/2009US20090247494 Omega-3 essential fatty acid composition and method for treatment of anal and colon-rectal disorders
10/01/2009US20090247493 Regimens for Treatment of Conditions Related to Estrogen Deficiency
10/01/2009US20090247492 Manganese based organometallic complexes, pharmaceutical compositions and dietetic products
10/01/2009US20090247491 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
10/01/2009US20090247490 Topical Compositions Containing Phosphorylated Polyphenols
10/01/2009US20090247489 Dihydroxyl compounds and compositions for cholesterol management and related uses
10/01/2009US20090247488 Anti-inflammatory phosphonate compounds
10/01/2009US20090247487 Combination Therapy to Treat Hepatitis B Virus
10/01/2009US20090247486 Composition for oral substance coating, covering material for oral substance, edible container and oral substance using the same
10/01/2009US20090247485 Barrier film-forming compositions and methods of use
10/01/2009US20090247484 Compounds
10/01/2009US20090247483 Method for Treatment of Macular Degeneration
10/01/2009US20090247482 50 Human Secreted Proteins
10/01/2009US20090247481 Compositions and Kits for Treating Influenza
10/01/2009US20090247480 Anti-cancer therapies
10/01/2009US20090247479 Therapeutic Use of Methionine to Reduce the Toxicity of Aminoglycoside Antibiotics
10/01/2009US20090247478 Novel macrolides and ketolides having antimicrobial activity
10/01/2009US20090247477 Methods of suppressing uv light-induced skin carcinogenesis
10/01/2009US20090247476 Mannitol and/or proline for prevention and treatment of ageing related symptoms
10/01/2009US20090247475 Methods and compositions relating to pharmacogenetics of different gene variants in the context of irinotecan-based therapies
10/01/2009US20090247473 Acythiols and component thiol compositions as anti-hiv and anti-retroviral agents
10/01/2009US20090247472 Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents
10/01/2009US20090247471 Inhibitors of cruzipain and other cysteine proteases
10/01/2009US20090247463 Polymer-based sustained release device
10/01/2009US20090247461 Methods for therapeutic treatment of pain
10/01/2009US20090247458 Compositions and methods for treating cystic fibrosis
10/01/2009US20090247455 Isolation of Inhibitors of IRES-Mediated Translation
10/01/2009US20090247452 comprising ziconotide, methionine and hydromorphone for producing analgesia in a mammalian subject; reduces the side effects, no drug interactions
10/01/2009US20090246296 Method of treating ischemia/reperfusion injury with nitroxyl donors
10/01/2009US20090246292 Antimicrobial formulations comprising a quinone and a copper salt
10/01/2009US20090246289 System and method for diagnosing and managing those at risk for cardiovascular disease
10/01/2009US20090246288 Taste-masking oral dosage form and method of preparing the same
10/01/2009US20090246287 Anti-allergy compositions
10/01/2009US20090246284 O-desmethylvenlafaxine Cocrystals
10/01/2009US20090246281 Soft steroid compositions for use in dry powder inhalers
10/01/2009US20090246277 Controlled release system
10/01/2009US20090246276 Pharmaceutical Compositions
10/01/2009US20090246274 Pharmaceutical composition 271
10/01/2009US20090246273 Ketorolac Sublingual Spray for the Treatment of Pain
10/01/2009US20090246271 Combination of ceramide and gemcitabine for inducing cell death and uses thereof in treating cancer
10/01/2009US20090246267 Carnitine Conjugates of Adamantanamines and Neramexane Derivatives as Dual Prodrugs for Various Uses
10/01/2009US20090246266 Preparation and composition of meloxicam transdermal drug delivery system
10/01/2009US20090246263 Adhesive preparation
10/01/2009US20090246262 Easily applied field dressing for wounds
10/01/2009US20090246257 Wafer formulation
10/01/2009US20090246256 Compositions and Methods for Transmucosal Delivery of Lofexidine
10/01/2009US20090246255 Pharmaceutical Compositions for the Treatment of Inner Ear Disorders
10/01/2009US20090246254 Non-hormonal vaginal contraceptive
10/01/2009US20090246252 Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery
10/01/2009US20090246233 Treatment of Gastroparesis and Nonulcer Dyspepsia With GABAB Agonists
10/01/2009US20090246232 Pharmaceutical composition
10/01/2009US20090246221 Immunomodulatory agents and methods of use
10/01/2009US20090246209 Gnrh analogues for treatment of urinary incontinence
10/01/2009US20090246201 Substances
10/01/2009US20090246198 Mapk/erk kinase inhibitors and methods of use thereof
10/01/2009US20090246196 Combined targeted therapy for the treatment of proliferative disease
10/01/2009US20090246189 Methods for Promoting Neurite Outgrowth and Survival of Dopaminergic Neurons
10/01/2009US20090246186 Agent for improving nervous system cell functions
10/01/2009US20090246185 Cardiac dysfunction-ameliorating agent or cardiac function-maintaining agent
10/01/2009US20090246183 eNOS mutations useful for gene therapy and therapeutic screening
10/01/2009US20090246180 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
10/01/2009US20090246176 Method for treating diabetes mellitus, obesity, chronic fatigue, aging, and other medical conditions by utilizing modified virus virions to insert messenger ribonucleic acid molecules into cells
10/01/2009US20090246174 Treatment for cutaneous t cell lymphoma
10/01/2009US20090246173 Treatment with anti-vegf antibodies
10/01/2009US20090246172 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
10/01/2009US20090246170 Therapeutic Agent For Alzheimer's Disease
10/01/2009US20090246169 Indolopyridines as eg5 kinesin modulators
10/01/2009US20090246167 Stimuli-responsive systems for controlled drug delivery
10/01/2009US20090246166 Pearl Like Polyvinyl Alcohol Particles, Production Process Thereof and Temporary Vascular Embolic Agent
10/01/2009US20090246165 Disinfectant with Quarternary Ammonium Polymer and Copolymers
10/01/2009US20090246164 Tissue adhesion
10/01/2009US20090246163 Anti-static skin products and method
10/01/2009US20090246162 Treatment of Chronic Progressive Heart Failure
10/01/2009US20090246161 Cationic capped dimer acid polyesters in personal care applications
10/01/2009US20090246154 Use of aminophenylbenzotriazole derivatives for protecting human and animal skin and hair from the harmful effects of uv radiation and cosmetic compositions thereof
10/01/2009US20090246153 Cosmetic compositions for the inhibition of reactive oxygen species
10/01/2009US20090246152 Naractin compositions for the inhibition of reactive oxygen species
10/01/2009US20090246147 Delivery Of Antipsychotics Through An Inhalation Route
10/01/2009US20090246145 Imaging Correlates of Neurogenesis With MRI
10/01/2009US20090246142 Triggered Self-Assembly of Nanoparticles In Vivo
10/01/2009US20090246137 Pyridyl derivatives as cftr modulators
10/01/2009US20090246136 Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration
10/01/2009CA2757023A1 24-hour extended-release metoclopramide
1 ... 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 ... 7860